➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Baxter
Johnson and Johnson
Boehringer Ingelheim
McKinsey

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Fougera Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for FOUGERA, and what generic and branded alternatives to FOUGERA drugs are available?

FOUGERA has one hundred and seventeen approved drugs.



Summary for Fougera
US Patents:0
Tradenames:55
Ingredients:47
NDAs:117

Drugs and US Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms ACLOVATE alclometasone dipropionate OINTMENT;TOPICAL 018702-001 Dec 14, 1982 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide OINTMENT;TOPICAL 088168-001 Dec 16, 1982 AT RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide CREAM;TOPICAL 088170-001 Dec 16, 1982 AT RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Fougera Pharms Inc HYDROCORTISONE hydrocortisone CREAM;TOPICAL 080693-003 Approved Prior to Jan 1, 1982 AT RX No Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Fougera Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate LOTION;TOPICAL 065067-001 Jan 31, 2002 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Fougera Pharms KETOCONAZOLE ketoconazole CREAM;TOPICAL 076294-001 Apr 28, 2004 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Fougera Pharms MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 075919-001 Nov 29, 2007 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Fougera

Paragraph IV (Patent) Challenges for FOUGERA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Lotion 0.05% ➤ Subscribe 2008-07-28
➤ Subscribe Topical Gel 3% ➤ Subscribe 2009-12-16
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Moodys
Boehringer Ingelheim
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.